2026-10-14T00:43:19Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34041295 2026-10-01T07:24:59Z category_37339 category_37348 category_37360 category_37366 category_37375 portal_1012 item_type_6 month_year_10_2026

Supplementary Data 1 from Preclinical Characterization of CLSP-1025, a First-in-Class, Mutation-Specific T-Cell Engager Targeting a Neoantigen Derived from a Common p53 Mutation Michael F. Maloney (25155127) Justina X. Caushi (25155130) Lenore A. Cullen (25155133) Alec R. Andrews (25155136) Amanda C. Ford (25155139) Anthony S. Gizzi (25155142) Catherine Souza (25155145) Kate L. Stokes (25155148) Veselin S. Dobrev (25155151) Kaleigh Krapfl (25155154) Madison Curtis Siok (25155157) David A. Orlando (20877945) James Bingham (25155160) Gillian A. Kingsbury (25155163) Cancer Cancer Biology Therapeutic Research and Development Clinical Research and Trials Methods and Technology Biological Agents & Therapies Bispecific antibodies Drug Mechanisms p53 and anticancer drug action Drug Targets Oncoprotein & tumor suppressor drug targets Oncogenes & Tumor Suppressors p53 Precision Medicine Preclinical Models In vitro models of cancer Organoids Xenograft models <p>Supplementary Appendix</p> 2026-10-01T00:00:00Z Text Journal contribution 10.1158/1078-0432.34041295 https://figshare.com/articles/journal_contribution/Supplementary_Data_1_from_Preclinical_Characterization_of_CLSP-1025_a_First-in-Class_Mutation-Specific_T-Cell_Engager_Targeting_a_Neoantigen_Derived_from_a_Common_p53_Mutation/34041295 CC BY